Afinitor Disperz — CareFirst (Caremark)
Classic Hodgkin lymphoma (relapsed or refractory)
Initial criteria
- Diagnosis of relapsed or refractory classic Hodgkin lymphoma
- Requested as single agent
Reauthorization criteria
- No evidence of unacceptable toxicity or disease progression while on current regimen
Approval duration
12 months